Target intelligence / Profile preview

Ribosomal protein L13a pseudogene 11 (RPL13AP11)

Target: RPL13AP11
Molecular classification: Other (Pseudogene)

Overview

RPL13AP11 is a pseudogene related to the ribosomal protein L13a gene. Pseudogenes are DNA sequences similar to known genes but are nonfunctional; they do not encode functional proteins and are typically not expressed or biologically active. RPL13AP11 is one among several processed pseudogenes derived from the ribosomal protein L13a gene (RPL13A). The canonical RPL13A encodes a structural component of the 60S ribosomal subunit, while RPL13AP11 itself serves no known biological role. Such pseudogenes are not considered therapeutic targets, do not interact with drugs, and are not implicated in disease except (rarely) as potential noncoding RNAs or genetic markers[1][3][5].

Other names: RPL13A_1_152RPL13AP11

Beyond the preview

Go deeper on Ribosomal protein L13a pseudogene 11 (RPL13AP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L13a pseudogene 11 (RPL13AP11).

Explore the full profile